MENU
Logo Made in Germany BIO 2018

News & Innovations

News and innovations published by German exhibitors

Current BioPark Financial Report 2017

The number of biotechnology companies (core Biotech definition according to CapGemini Consulting) has risen compared to last year to 33 companies (+ 3). The number of biotech employees has slightly fallen from 1,152 to 1,108 (- 4 %) due to company restructuring. Concurrently the number of...

Exhibitor: BioPark Regensburg GmbH

Winner 2018 CRO Leadership Award

  “The whole bioskin team is honored and grateful that we received  the CRO Leadership Award in the categories Capability, Expertise, Quality and Reliability. With over 25 years of experience dedicated to clinical research in dermatology, bioskin offers...

Exhibitor: bioskin GmbH

Lynda Sutton, principle and cofounder of Cato BioVentures, featured in BioWorld's article titled, "Alternative to traditional venture capital money could fill translational gaps" by Jennifer Boggs, fo

Lynda Sutton, principle and cofounder of Cato BioVentures, a family owned venture capital of Cato Holdings, was recently featured in BioWorld's article titled, "Alternative to traditional venture capital money could fill translational gaps" by Jennifer Boggs, for her panel discussion at this...

Exhibitor: cato Europe GmbH

ChemCon wins CMO Leadership Award in five core categories

ChemCon GmbH, Contract Manufacturing Organization (CMO) for specialty drug substances and fine chemicals, has won awards in five categories of the 2018 CMO Leadership Awards: Capabilities, Compatibility, Expertise, Quality and Service in the groups Small Pharma and Overall. Dr. Raphael Vogler,...

Exhibitor: ChemCon GmbH

Fraunhofer launches a pioneering collaboration: the German-Australian iCAIR project

Battling infection and resistance Researchers from the Fraunhofer Institute for Toxicology and Experimental Medicine ITEM have teamed up with colleagues from the Hannover Medical School (MHH) and Griffith University’s Institute for Glycomics (IfG) in Gold Coast, Australia, in the iCAIR...

Exhibitor: Fraunhofer Institut für Toxikologie und Experimentelle Medizin ITEM

Research alliance launched, aimed at establishing bacteriophages as an approved drug

Bacteriophages join the fight against infection Bacteria worldwide keep developing new resistances to antibiotics. Alternative therapies are urgently needed to meet this challenge. To this end, Fraunhofer ITEM, Leibniz Institute DSM-German Collection of Microorganisms and Cell Cultures, Charité...

Exhibitor: Fraunhofer Institut für Toxikologie und Experimentelle Medizin ITEM

eTRANSAFE – collaborative research project aimed at improving safety in the drug development process

The 40 million euro European project eTRANSAFE, kicked off at the end of September 2017, is aimed at speeding up the development of better and safer medicines for patients. Coordinated by the Fundació Institut Mar d'Investigacions Mèdiques and led by the pharmaceutical company Novartis, the...

Exhibitor: Fraunhofer Institut für Toxikologie und Experimentelle Medizin ITEM

Identifying key regulators of diseases

The key uniqueness of the geneXplain platform integrated with TRANSFAC and TRANSPATH databases is its ability to analyze genome regulatory regions and identify the key regulators of a disease under study. The complexes of transcription factors binding sites (TFBS), which are responsible for the...

Exhibitor: geneXplain GmbH

Genekam DNA-Test for detection of yellow fever virus (a new threat to the world)

Genekam Biotechnology AG, Germany has developed a new DNA kit for detection of yellow fever virus. This kit is with CE-IVD and can be used in diagnostic in Europe and other CE accepting countries. At present, there are outbreaks of yellow fever in Africa and WHO is keeping a close eye on...

Exhibitor: Genekam Biotechnology AG

DNA-Test for detection of influenza viruses H5N8 and H5N6 and H4N7

Genekam Biotechnology AG has just developed two different kits for two different viruses, which are breaking out in many countries. H5N6 is infecting human beings also particularly a few cases are being reported in China and it may spread to our countries. H5N8 is breaking out in birds at present...

Exhibitor: Genekam Biotechnology AG

World Innovation and Hope: First therapeutic molecule candidate against Zika viruses

Genekam Biotechnology AG, which developed the first test for Zikavrius detection in Januar 2016, has developed as one of first company in the world the therapeutic molecule candidate for Zika viruses, which is likely to be the first potential candidate for Zika-virus therapy. Zika viruses are...

Exhibitor: Genekam Biotechnology AG

LifeAct-TagGFP2 Protein—Immediate F-Actin Visualization in Living and Fixed Cells

Achieve fast staining and immediate functional analysis of filamentous actin (F-actin) in living and fixed cells with ibidi’s new reagent, LifeAct-TagGFP2 Protein. The addition of this recombinant protein extends the successful ibidi LifeAct product line for F-actin visualization and offers an...

Exhibitor: ibidi GmbH

Perform Up to Four Parallel Cellular Microscopy Assays in One Single Dish

The latest, innovative product release from ibidi is the µ-Dish 35 mm Quad, a four-compartment cell culture dish that can be used for simultaneous assays, and it guarantees brilliant optical quality. Using this 35 mm imaging dish, researchers will benefit significantly from the quartered...

Exhibitor: ibidi GmbH

Speed up Your Workflow with ACAS Automated Image Analysis

ibidi introduces a fast, new web-based tool, ACAS (Automated Cellular Analysis System), which offers extremely quick and reliable analysis of wound healing and angiogenesis assays. This lean and efficient software is the latest addition to ibidi’s already innovative product portfolio, which...

Exhibitor: ibidi GmbH

Project Center Stem Cell Process Technology Würzburg

The Fraunhofer IBMT started in cooperation with the Fraunhofer ISC, the Project Center Stem Cell Process Technology Würzburg to generate standardized, high-quality induced pluripotent stem cells in large quantities for pharmaceutical research and mature & physiological cell models for drug...

Exhibitor: Fraunhofer Institut für Biomedizinische Technik IBMT

Growing human stem cells - Laboratory in a bag

Human stem cells are a major new hope in the field of medicine. With LabBag®, Fraunhofer IBMT researchers have developed an all-in-one system in the form of a transparent bag that provides a cheap, fast and sterile way for scientists to grow, differentiate and freeze stem cells. The cell models...

Exhibitor: Fraunhofer Institut für Biomedizinische Technik IBMT

Ultrasound technology wirelessly powers active implants

Unlike drugs, active implants such as electroceuticals act locally, have fewer side effects and function directly through electrical signals, much like the body itself. Fraunhofer IBMT has developed a new technology platform that can power active implants wirelessly via ultrasound. The experts...

Exhibitor: Fraunhofer Institut für Biomedizinische Technik IBMT

Comprehensive services

  Health Economics & Outcomes Research -> Value demonstration -Dossiers for early benefit assessment and clinical evaluation of drugs -Health Technology Assessment (HTA) Market analysis ->Assessment of inpatient and ambulatory sector potentials ->Competition and regulation...

Exhibitor: IGES Institut GmbH

Our CI-SCREEN Technology has been published in Nature Communications ..

Use functionally immortalized cell systems as an alternative to freshly isolated primary cells. CI-SCREEN cell lines from various tissue and species can be applied for drug screening, characterization and personalized medicine.

Exhibitor: InSCREENeX GmbH

beta,beta-Dimethyl Amino Acids

Recent commercial successes, e.g. of GLP-1 analogues such as Liraglutide and Semaglutide, encouraged the development of peptides as therapeutic agents and large-scale synthesis of peptide APIs. However, their inherent susceptibility to proteolytic degradation resulting in rapid elimination in...

Exhibitor: Iris Biotech GmbH

Maillard Reaction Products

Proteins contained in meat and other comestible goods are usually rich in the amino acids arginine and lysine. The side chain functional groups of Arg and Lys react with reducing carbohydrates such as glucose or lactose to form Amadori reaction products. These characteristic intermediates...

Exhibitor: Iris Biotech GmbH

Poly(Amino Acids)

Poly(amino acids) are valuable alternatives to PEG. Unlike PEGs, poly(amino acids) are biocompatible and biodegradable. Polyarginines are known for their ability to enhance cell penetration. Other applications include the formation of PolyArg nanocapsules and the mediation of peptide–carbon...

Exhibitor: Iris Biotech GmbH

Start of clinical trial with TCR immunotherapy MDG1011

Target: PRAME (Preferentially Expressed Antigen in Melanoma) is a well characterized tumor antigen overexpressed in multiple hematological and solid tumor indications The drug, MDG1011: T cells expressing a HLA-A*02:01-restricted T cell receptor (TCR) specific for PRAME Trial outline: 1)...

Exhibitor: Medigene AG

MorphoSys Announces That Tremfya(R) (Guselkumab) Data Demonstrated Long-Term Skin Clearance In Patients With Moderate-To-Severe Plaque Psoriasis

MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) announced today that its licensee Janssen Research & Development, LLC (Janssen) reported data from the Phase 3 VOYAGE 2 study of TREMFYA(R) (guselkumab), which demonstrated long-term skin clearance in patients with moderate to...

Exhibitor: Morphosys AG

MorphoSys Signs Regional License Agreement for Antibody MOR202 with I-Mab

MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) and I-Mab announced today that they have entered into an exclusive regional licensing agreement to develop and commercialize MOR202 in China, Taiwan, Hong Kong and Macao. MOR202 is MorphoSys's proprietary investigational antibody...

Exhibitor: Morphosys AG

MorphoSys and Galapagos Present Results from a Phase 1 Study with MOR106 in Atopic Dermatitis as Late-Breaking Abstract at the American Academy of Dermatology (AAD) Meeting in San Diego

MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) and Galapagos NV (Euronext & NASDAQ: GLPG) announced the presentation of more detailed results of the Phase 1 study with the investigational IL-17C antibody MOR106 in AD patients at the American Academy of Dermatology (AAD)...

Exhibitor: Morphosys AG

Image management platform ERICA

In 2017 pharmtrace launched its validated GCP-compliant image management platform (ERICA) as a “cloud enabled” SaaS ("Software as a Service") platform to enable customers directly manage their clinical trial images and to take full control of all imaging-related workflows. pharmtrace provides the...

Exhibitor: pharmtrace klinische Entwicklung GmbH

Your personal organizer

Your personal organizer

Print list  |  Save as PDF
This is your personal organizer to manage your contacts to the German exhibitors.